发明授权
EP1636584B1 USE OF PROTEIN CELLULAR RETINOIC ACID-BINDING PROTEIN II (CRABP II) AS MARKER FOR BREAST CANCER
有权
中蛋白质CRABP II（CELLULAR视黄酸结合蛋白II）作为标志物用于乳腺癌USE
- 专利标题： USE OF PROTEIN CELLULAR RETINOIC ACID-BINDING PROTEIN II (CRABP II) AS MARKER FOR BREAST CANCER
- 专利标题（中）： 中蛋白质CRABP II（CELLULAR视黄酸结合蛋白II）作为标志物用于乳腺癌USE
-
申请号： EP04739585.0申请日： 2004-06-04
-
公开(公告)号： EP1636584B1公开(公告)日： 2007-04-11
- 发明人: PESTLIN, Gabriele , ANDRES, Herbert , BERNDT, Peter , HAGMANN, Marie-Luise , KARL, Johann , LANGEN, Hanno , ZOLG, Werner
- 申请人： Roche Diagnostics GmbH , F. HOFFMANN-LA ROCHE AG
- 申请人地址： Sandhofer Strasse 116 68305 Mannheim DE
- 专利权人： Roche Diagnostics GmbH,F. HOFFMANN-LA ROCHE AG
- 当前专利权人： Roche Diagnostics GmbH,F. HOFFMANN-LA ROCHE AG
- 当前专利权人地址： Sandhofer Strasse 116 68305 Mannheim DE
- 优先权： EP03012942 20030606
- 国际公布： WO2004111650 20041223
- 主分类号： G01N33/574
- IPC分类号： G01N33/574
摘要：
The present invention relates to the diagnosis of breast cancer. It discloses the use of protein cellular retinoic acid-binding protein II in the diagnosis of breast cancer. It relates to a method for diagnosis of breast cancer from a liquid sample, derived from an individual by measuring cellular retinoic acid-binding protein II in said sample. Measurement of cellular retinoic acid-binding protein II can, e.g., be used in the early detection or diagnosis of breast cancer.
公开/授权文献
信息查询
IPC分类:
